San Francisco Examiner - September 17, 2004
Proposition 71 would have the state borrow $3 billion to fund stem cell research over 10 years. The bond measure would create a new California Institute for Regenerative Medicine, as well as a citizen oversight committee, to promote the new scientific field. Over 30 years, it would cost the state roughly $6 billion altogether, while funding research and potentially generating many patents and spinoff businesses that could boost the state's economy.
That contribution dwarfs all other support combined, including the $25 million provided by the federal government last year. Never before has a state attempted such a massive medical research effort on its own. Such expensive scientific undertakings are usually left to the National Institutes of Health, which has an annual budget exceeding $30 billion.
Proponents say the results might benefit as many as 128 million Americans affected by cancer, heart disease, diabetes, Alzheimer's, Parkinson's, HIV/AIDS, multiple sclerosis, lung disease and spinal injuries. Since federal dollars are now limited to research involving existing stem cell lines, this measure would be enacted to fill the gaps in existing funding. Proponents also claim the Bush administration is hindering advances in the field by restricting federal funding.
Opponents, such as state Sen. Tom McClintock, R-Thousand Oaks, charge that the measure is too costly, will lead to state indebtedness over time, and amounts to "corporate welfare."
040917
SE040902
Copyright © 2004 - San Francisco Examiner. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Examiner, Permissions Desk, 110 Fifth Street, P.O. Box 7260, San Franciso, CA 94120.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .